T. Rowe Price Associates’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.3M Buy
1,492,322
+230,394
+18% +$7.31M ﹤0.01% 833
2025
Q4
$40.8M Sell
1,261,928
-665,869
-35% -$19.5M ﹤0.01% 866
2025
Q3
$55.2M Buy
1,927,797
+75,071
+4% +$2.26M 0.01% 777
2025
Q2
$55M Buy
1,852,726
+67,463
+4% +$2.1M 0.01% 705
2025
Q1
$59.2M Buy
1,785,263
+21,290
+1% +$757K 0.01% 672
2024
Q4
$60.4M Buy
1,763,973
+198,551
+13% +$7.47M 0.01% 698
2024
Q3
$56.7M Buy
1,565,422
+106,731
+7% +$3.75M 0.01% 719
2024
Q2
$49.8M Buy
1,458,691
+5,058
+0.3% +$173K 0.01% 726
2024
Q1
$50M Sell
1,453,633
-4,996
-0.3% -$163K 0.01% 728
2023
Q4
$49.6M Buy
1,458,629
+15,438
+1% +$462K 0.01% 714
2023
Q3
$38.8M Sell
1,443,191
-38,259
-3% -$1.12M 0.01% 760
2023
Q2
$48.6M Buy
1,481,450
+79,444
+6% +$2.47M 0.01% 713
2023
Q1
$42.5M Sell
1,402,006
-47,548
-3% -$1.37M 0.01% 722
2022
Q4
$36.9M Sell
1,449,554
-47,279
-3% -$1.17M 0.01% 747
2022
Q3
$31.5M Sell
1,496,833
-41,367
-3% -$1.02M 0.01% 773
2022
Q2
$34M Buy
1,538,200
+1,362,617
+776% +$34.6M ﹤0.01% 1002
2022
Q1
$4.32M Buy
175,583
+5,845
+3% +$163K ﹤0.01% 1492
2021
Q4
$5.62M Buy
169,738
+6,318
+4% +$200K ﹤0.01% 1484
2021
Q3
$4.77M Sell
163,420
-7,556
-4% -$226K ﹤0.01% 1515
2021
Q2
$5.21M Sell
170,976
-1,969
-1% -$62.3K ﹤0.01% 1497
2021
Q1
$5.12M Buy
172,945
+1,373
+0.8% +$39.3K ﹤0.01% 1463
2020
Q4
$4.9M Buy
171,572
+62
+0% +$1.69K ﹤0.01% 1444
2020
Q3
$3.8M Sell
171,510
-218,898
-56% -$5.07M ﹤0.01% 1436
2020
Q2
$8.8M Sell
390,408
-44,251
-10% -$905K ﹤0.01% 1316
2020
Q1
$7.51M Sell
434,659
-51,380
-11% -$1.31M ﹤0.01% 1273
2019
Q4
$14.8M Sell
486,039
-19,404
-4% -$572K ﹤0.01% 1244
2019
Q3
$15.2M Sell
505,443
-4,098
-0.8% -$121K ﹤0.01% 1225
2019
Q2
$15.2M Buy
509,541
+2,381
+0.5% +$63.1K ﹤0.01% 1252
2019
Q1
$12.8M Buy
507,160
+33,112
+7% +$852K ﹤0.01% 1283
2018
Q4
$11.1M Buy
474,048
+60,170
+15% +$1.49M ﹤0.01% 1294
2018
Q3
$12.1M Buy
413,878
+15,473
+4% +$464K ﹤0.01% 1340
2018
Q2
$12.1M Sell
398,405
-19,696
-5% -$618K ﹤0.01% 1311
2018
Q1
$12.6M Sell
418,101
-1,313,466
-76% -$41.1M ﹤0.01% 1294
2017
Q4
$56M Buy
1,731,567
+1,659,250
+2,294% +$52.6M 0.01% 825
2017
Q3
$2.09M Sell
72,317
-491,909
-87% -$14.9M ﹤0.01% 1564
2017
Q2
$18.1M Sell
564,226
-48,537
-8% -$1.55M ﹤0.01% 1203
2017
Q1
$19.7M Buy
612,763
+543,374
+783% +$16.1M ﹤0.01% 1169
2016
Q4
$1.89M Buy
69,389
+16,017
+30% +$422K ﹤0.01% 1580
2016
Q3
$1.51M Buy
53,372
+5,900
+12% +$165K ﹤0.01% 1613
2016
Q2
$1.26M Buy
47,472
+2,957
+7% +$83.7K ﹤0.01% 1633
2016
Q1
$1.3M Buy
44,515
+6,010
+16% +$153K ﹤0.01% 1637
2015
Q4
$1.03M Buy
38,505
+14,205
+58% +$397K ﹤0.01% 1683
2015
Q3
$616K Buy
+24,300
New +$722K ﹤0.01% 1859

Other funds holding AXTA

T. Rowe Price Associates's AXTA Position: Q1 2026 in Review

T. Rowe Price Associates increased its Axalta (AXTA) stake by 18% in Q1 2026, buying an estimated $7.31M and bringing the position to 1,492,322 shares worth $41.3M. The position accounts for ﹤0.01% of the portfolio, ranked #833.

T. Rowe Price Associates first reported a position in AXTA in Q3 2015 and has held it in 43 quarters since. The position peaked at $60.4M in Q4 2024. 381 funds tracked by Wall St. Rank hold AXTA as of Q1 2026.

  • T. Rowe Price Associates held 1,492,322 shares of Axalta worth $41.3M as of Q1 2026.
  • T. Rowe Price Associates bought 230,394 Axalta shares in Q1 2026, an estimated $7.31M.
  • Axalta made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #833 holding.
  • T. Rowe Price Associates first reported a position in Axalta in Q3 2015 and has held it in 43 quarters since.
  • T. Rowe Price Associates's Axalta position peaked at $60.4M in Q4 2024.
  • 381 funds tracked by Wall St. Rank held Axalta as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.